These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1071952)

  • 61. [Effects of propranolol and pindolol on cardiovascular and plasma catecholamine and renin responses to exercise (author's transl)].
    Teshigawara H; Okajima S; Mizuno Y; Ohashi S; Okutani M
    Kokyu To Junkan; 1981 Jul; 29(7):731-5. PubMed ID: 7027387
    [No Abstract]   [Full Text] [Related]  

  • 62. Response of plasma catecholamines and blood pressure to clonidine and to sudden withdrawal of the drug in subjects with essential hypertension.
    Planz G; Beckenbauer U; Bundschu HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):474-8. PubMed ID: 7141755
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Suppressed plasma renin activity in essential hypertension. Roles of plasma volume, blood pressure, and sympathetic nervous system.
    Jose A; Crout JR; Kaplan NM
    Ann Intern Med; 1970 Jan; 72(1):9-16. PubMed ID: 4312105
    [No Abstract]   [Full Text] [Related]  

  • 64. Adrenergic receptor mediation of renin secretion.
    Winer N; Chokshi DS; Yoon MS; Freedman AD
    J Clin Endocrinol Metab; 1969 Sep; 29(9):1168-75. PubMed ID: 4390114
    [No Abstract]   [Full Text] [Related]  

  • 65. [Effects of propranolol on the dynamic changes of plasma-renin-activity in essential arterial hypertension].
    Gragnoli G; Palazzuoli V; Tanganelli I; Favilli R
    Cardiol Prat; 1975; 26(1):11-7. PubMed ID: 1222397
    [No Abstract]   [Full Text] [Related]  

  • 66. [Catecholamines, prostaglandins and intracellular electrolyte levels in patients with hypertension and low plasma renin activity].
    Wocial B; Jabłońska-Skwiecińska E; Chodakowska J; Feltynowski T; Ignatowska-Switalska H; Pawłowski W; Chojnowski K; Januszewicz W
    Kardiol Pol; 1987; 30(9):545-54. PubMed ID: 3320452
    [No Abstract]   [Full Text] [Related]  

  • 67. Catecholamines and essential hypertension.
    Robertson D; Nies AS
    J S C Med Assoc; 1977 Dec; 73(12):519-22. PubMed ID: 338988
    [No Abstract]   [Full Text] [Related]  

  • 68. Contributions of central sympathetic neural activity to furosemide-induced increases in plasma renin activity and noradrenaline.
    Ueno Y; Arita M; Suruda H; Mohara O; Masuyama Y
    Jpn Heart J; 1983 Mar; 24(2):259-67. PubMed ID: 6343667
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mechanism of the antihypertensive effect of propranolol.
    Bhagat BD
    Gen Pharmacol; 1979; 10(4):291-6. PubMed ID: 39875
    [No Abstract]   [Full Text] [Related]  

  • 70. Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in man.
    Barbe P; Galitzky J; Riviere D; Senard JM; Lafontan M; Garrigues M; Berlan M
    Br J Clin Pharmacol; 1993 Jul; 36(1):25-30. PubMed ID: 8373709
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sympathetic neural activation evoked by mu-receptor blockade in patients addicted to opioids is abolished by intravenous clonidine.
    Kienbaum P; Heuter T; Michel MC; Scherbaum N; Gastpar M; Peters J
    Anesthesiology; 2002 Feb; 96(2):346-51. PubMed ID: 11818767
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combined adrenergic receptor blockade and circulating catecholamines in hemorrhagic shock.
    Halmagyi DF; Kennedy M; Varga D
    Eur Surg Res; 1971; 3(6):378-88. PubMed ID: 5158951
    [No Abstract]   [Full Text] [Related]  

  • 73. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans.
    Pernow J; Lundberg JM; Kaijser L
    J Cardiovasc Pharmacol; 1988; 12(5):593-9. PubMed ID: 2468060
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin.
    Malmqvist K; Ohman KP; Lind L; Nyström F; Kahan T
    J Intern Med; 2002 Nov; 252(5):430-9. PubMed ID: 12528761
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Catecholamines and essential hypertension.
    Christensen NJ
    Scand J Clin Lab Invest; 1982 May; 42(3):211-5. PubMed ID: 6753096
    [No Abstract]   [Full Text] [Related]  

  • 76. I1-imidazoline agonist moxonidine decreases sympathetic nerve activity and blood pressure in hypertensives.
    Wenzel RR; Spieker L; Qui S; Shaw S; Lüscher TF; Noll G
    Hypertension; 1998 Dec; 32(6):1022-7. PubMed ID: 9856967
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Can determination of catecholamines in the blood reflect slight changes in sympathetic activity?].
    Ferrari A; Parati G; Pomidossi G; Bertinieri G; Grassi G; Gregorini L; Picotti GB; Leonetti G; Mancia G
    Boll Soc Ital Cardiol; 1980; 25(11):1265-9. PubMed ID: 7326131
    [No Abstract]   [Full Text] [Related]  

  • 78. [The sympathetic nervous system and essential hypertension].
    Distler A
    Med Klin; 1979 Nov; 74(47):1735-41. PubMed ID: 392290
    [No Abstract]   [Full Text] [Related]  

  • 79. Left ventricular wall thickness and plasma catecholamines in borderline and stable essential hypertension.
    Corea L; Bentivoglio M; Verdecchia P; Motolese M
    Eur Heart J; 1982 Apr; 3(2):164-70. PubMed ID: 6211357
    [No Abstract]   [Full Text] [Related]  

  • 80. [Influence of exercise on plasma concentration of neuropeptide Y in patients with essential hypertension].
    Zyśko D
    Pol Merkur Lekarski; 2003 Sep; 15(87):244-8. PubMed ID: 14679849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.